Belgium· BE-AMP-SAM138573-00
Xanthium - 200 200 mg
A theophylline product containing theophylline monohydrate, registered in Belgium by Laboratoires S.M.B.. The same ATC class is registered in 12 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Theophylline is registered in 12 of 19 countries.
Countries holding a registration under ATC R03DA04 (theophylline), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
Theophylline · ATC R03DA04
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Japan
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of theophylline costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Theophylline · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- US United States$0.71 (acquisition cost)
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Theophylline Monohydrate
- Manufacturer
- Laboratoires S.M.B.
- Country
- Belgium (BE)
- ATC code
- R03DA04
- ATC class
- Theophylline
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
1 priced- be_apb0835454EUR 9.08
- be_apb0730721
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
438 interactions on record for theophylline.
Graded by severity as the source publishes them — 34 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Theophylline · interactions on record
438 records
- 34 severe
- 222 moderate
- 45 minor
- 132 info
Most severe, free to view
- MexiletineC01BB02severe
- RiociguatC02KX05severe
- PindololC07AA03severe
- PropranololC07AA05severe
5 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Theophylline in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaEUPHYLLIN CR NAstraZeneca AB, Södertälje
- FranceDILATRANE 200 mg, gélule à libération prolongéeSERP
- NorwayBronchoretard miteGlenwood
- FinlandXanthiumHexal AG
- PolandEuphyllin longpharmaand GmbH
- United StatesTheo-24ENDO USA, Inc.
- United KingdomNuelin 125mg tablets3M Health Care Ltd
- Japanテオフィリン田辺ファーマ
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Theospirex, Theospirex Retard
- Bulgaria · Теотард
- Cyprus · Theo-Dur
- Czechia · Euphyllin Cr N
- Germany · Afpred Forte-Theo, Bronchoretard
- Denmark · Theo-Dur, Unixan
- Estonia · Teotard
- Spain · Elixifilin, Teromol Retard
- Finland · Retafyllin
- France · Dilatrane, Tedralan
- United Kingdom (Northern Ireland) · Uniphyllin
- Greece · Theo-Bros, Theo-Dur
- Croatia · Teotard
- Hungary · Theophyllini Fono Vii. Naturland, Theophyllini Fono Viii. Parma
- Ireland · Uniphyllin
- Lithuania · Teotard
- Luxembourg · Xanthium
- Latvia · Teotard
- Norway · Theo-Dur
- Poland · Euphyllin Long, Theophyllinum Tramco
- Portugal · Unicontin
- Romania · Teotard
- Sweden · Theo-Dur
- Slovenia · Teotard
- Slovakia · Euphyllin Cr N 200, Euphyllin Cr N 300
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0f03bb0b-01b8-475b-94f0-39d779d8c47c GET /v1/drugs/0f03bb0b-01b8-475b-94f0-39d779d8c47c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Prolonged-release capsule, hard",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Xanthium - 200 200 mg",
"name_fr": "Xanthium - 200 200 mg",
"name_nl": "Xanthium - 200 200 mg",
"amp_code": "SAM138573-00",
"strengths": [
"200.0000",
"13.1900",
"0.0600"
],
"pack_count": 3,
"substances": [
"Theophylline Monohydrate",
"Theophylline",
"Sucrose Monostearate",
"Polysorbate 80"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Theophylline",
"authorisation_numbers": [
"BE138573"
]
}See everything about theophylline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.